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Background. The importance of gut bacteria in human physiology, immune regulation, and disease pathogenesis is well estab-
lished. In contrast, the composition and dynamics of the gut virome are largely unknown; particularly lacking are studies in preg-
nancy. We used comprehensive virome capture sequencing to characterize the gut virome of pregnant women with and without type 
1 diabetes (T1D), longitudinally followed in the Environmental Determinants of Islet Autoimmunity study.
Methods. In total, 61 pregnant women (35 with T1D and 26 without) from Australia were examined. Nucleic acid was extracted 
from serial fecal specimens obtained at prenatal visits, and viral genomes were sequenced by virome capture enrichment. The fre-
quency, richness, and abundance of viruses were compared between women with and without T1D.
Results. Two viruses were more prevalent in pregnant women with T1D: picobirnaviruses (odds ratio [OR], 4.2; 95% confidence 
interval [CI], 1.0–17.1; P = .046) and tobamoviruses (OR, 3.2; 95% CI, 1.1–9.3; P = .037). The abundance of 77 viruses significantly 
differed between the 2 maternal groups (≥2-fold difference; P < .02), including 8 Enterovirus B types present at a higher abundance 
in women with T1D.
Conclusions. These findings provide novel insight into the composition of the gut virome during pregnancy and demonstrate a 
distinct profile of viruses in women with T1D.
Keywords. enterovirus; pregnancy; type 1 diabetes; virome capture sequencing.
Pregnancy is a complex immunological state in which the bal-
ance between an inimical alloimmune response and an envi-
ronment of maternal tolerance may be perturbed by virus 
infections [1], potentially resulting in significant perinatal 
morbidity [2]. Helper T-lymphocyte (Th)-associated cytokines 
shift from Th1 towards Th2 to protect the fetus; however, this 
Th2 bias can diminish cell-mediated immunity and increase 
vulnerability to intracellular infections, including viruses [3–5]. 
In pregnant women with type 1 diabetes (T1D), hyperglyce-
mia may impede pathogen clearance, increasing the duration 
of gestational infections [6] and heightening the risk of adverse 
outcomes in the fetus, including subsequent development of 
T1D during childhood [7]. This is supported by our recent sys-
tematic review and meta-analysis of 2992 women and children, 
which demonstrated a significant association between maternal 
virus infection in pregnancy and T1D in offspring (odds ratio 
[OR], 2.2; 95% confidence interval [CI], 1.2–3.8; P = .008) [8]. 
To date, no study has examined the gut virome during preg-
nancy and how it may be altered by T1D.
METHODS
Study Population and Sample Selection
The gut virome of 61 pregnant women (35 with T1D and 26 
without) in the ENDIA (Environmental Determinants of Islet 
Autoimmunity) study (Australian New Zealand Clinical Trials 
Registry registration number ACTRN12613000794707) was 
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examined (Supplementary Table 1). ENDIA is a prospective 
cohort study of children at risk of T1D (have ≥1 first-degree 
relative with T1D), followed longitudinally from pregnancy to 
3  years of life [9]. Women recruited between 2012 and 2016 
were included in this analysis. Overall, 59 pregnancies were 
singleton and 2 were twin pregnancies. Fecal samples were col-
lected during the first (n = 18), second (n = 47), and/or third tri-
mester of pregnancy (n = 59), which were defined as gestational 
age of 1–14, 15–26, and 27–42 weeks, respectively. All samples 
were stored at −80oC in aliquots before analysis. For every par-
ticipant, all available samples were examined. In total, 49 of 61 
women had samples for multiple timepoints and 12 of 61 had 
samples for all 3 trimesters.
The study was reviewed and approved (July 13, 2016) by the 
study’s lead Human Research Ethics Committee at the Women’s 
and Children’s Health Network under the National Mutual 
Acceptance Scheme (HREC/16/WCHN/66) and at all partici-
pating study sites in Australia. All participants provided written 
informed consent and were free to withdraw from the study at 
any time. Families were excluded if the mother could not com-
prehend her participation in the study and therefore was unable 
to provide informed consent.
Nucleic Acid Extraction
Total nucleic acid (NA) was extracted using the MagMAX Total 
NA Isolation Kit (Thermo Fisher Scientific) on the semi-auto-
mated KingFisher FLEX Purification System (Thermo Fisher 
Scientific), following manufacturer’s guidelines with minor 
modifications. Thirty percent (w/v) of fecal suspensions were 
prepared in 1× phosphate-buffered saline and centrifuged for 
5 minutes. All spin steps were performed at 13 000 ×g at room 
temperature. After centrifugation, 175  μL supernatant was 
transferred to zirconium bead tubes containing 235 μL Lysis/
Binding Solution. Bead tubes were shaken at 2400 rpm on the 
Bioshake iQ (Quantifoil Instruments, Jena, Germany) for 15 
minutes, then centrifuged 3 minutes. Into new tubes, 300  μL 
lysate was transferred and further centrifuged for 6 minutes. 
Total NA was purified from 200 μL lysate and stored at −80oC.
Sequence-Independent Amplification
Total NA was subjected to complementary deoxyribonucleic 
acid (cDNA) synthesis and sequence-independent preamplifica-
tion (SIP) using the Transplex Complete Whole Transcriptome 
Amplification Kit (WTA1; Sigma-Aldrich, St. Louis, MO), fol-
lowing a published protocol [10]. In brief, 3.5 μL total NA was 
denatured at 95oC for 5 minutes instead of 70oC before cDNA 
synthesis to ensure amplification of both DNA and ribonucleic 
acid (RNA) molecules. Denatured NA was cooled to 18oC, and 
cDNA was synthesized using the following thermocycling condi-
tions: 18oC 10 minutes, 25oC 10 minutes, 37oC 30 minutes, 42oC 
10 minutes, 70oC 20 minutes, and 4oC holding. The entire cDNA 
library was used as template for SIP using the following cycling 
conditions repeated 22 times: 94oC 30 seconds and 70oC 5 min-
utes. After amplification, polymerase chain reaction (PCR) prod-
ucts were visualized on an agarose gel before purification using the 
ChargeSwitch-Pro PCR CleanUp Kit (Thermo Fisher Scientific).
Virome Capture Sequencing
One microgram of double-stranded DNA (dsDNA) was used 
for library synthesis using the KAPA Hyperplus kit (KAPA 
Biosystems, Wilmington, MA) with single-index adapters. 
In brief, dsDNA was enzymatically fragmented to an average 
of 200 base pairs. Fragments were purified using AmpureXP 
beads (Beckman Coulter, Brea, CA). Libraries were amplified 
for 6–9 cycles, quality checked on the LabChip GX Touch 24 
Bioanalyzer (PerkinElmer, Waltham, MA), and quantified using 
the picogreen assay (Thermo Fisher Scientific) on the Victor X2 
Fluorescent Microplate Reader (PerkinElmer). Completed librar-
ies were pooled by equal mass for sequence capture. VirCapSeq-
VERT was performed according to the Nimblegen SeqCap 
protocol (Roche, Basel, Switzerland) as described previously [11]. 
Postcapture libraries were purified and amplified before sequenc-
ing. To ensure sufficient depth of coverage (approximately 10 mil-
lion unique sequence reads/sample), uniquely barcoded samples 
were pooled at a maximum of 20 libraries per pool (20-plex) and 
sequenced on a lane of HiSeq 4000 (Illumina, San Diego, CA).
Genome Sequence Analysis
Genome assembly, contig generation, and taxonomic clas-
sification of reads were performed as previously described 
[11]. Demultiplexed and quality-trimmed sequence reads 
were aligned against host reference databases from GenBank 
(National Center for Biotechnology Information) using the 
Bowtie2 mapping algorithm (version 2.1.0) [12] to remove the 
host background. Filtered reads were assembled de novo using 
either SOAPdenovo2 [13], MEGAHIT [14], or MIRA assem-
blers [15], then contigs and unique singletons were subjected 
to homology search at the nucleotide level using MegaBLAST. 
Sequences that exhibited poor or no homology at the nucleo-
tide level were screened further by BLASTX against the viral 
GenBank protein database. Viral sequences detected from 
BLASTX analysis were subjected to another round of BLASTX 
homology search against the entire GenBank protein database 
to correct for biased E values and inaccurate taxonomic clas-
sifications. For reference-based alignments, to visualize depth 
and spread of coverage for individual viruses, both Integrated 
Genomics Viewer [16] and Geneious (version 9.0.5) [17] were 
used. After taxonomic classification, read counts were corrected 
to account for sample bleeding due to Illumina index cross-talk, 
where sequences with single index barcodes are erroneously 
sorted, resulting in approximately 0.1% of total reads being dis-
tributed to the incorrect sample Fastq file. Cutoffs were applied 
across each pool separately. For each virus, 0.1% of the highest 
read count in that pool was calculated and subtracted from the 
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number of reads of that virus in each sample. All resulting read 
counts below 1 were corrected to zero. This process minimized 
the risk of false-“positive” identification of viruses in samples. To 
evaluate virus positivity, a threshold of 100 viral reads matched 
by Basic Local Alignment Search Tool (BLAST) at the species 
level, randomly distributed over the target genome, was applied. 
This threshold was selected for its proximity to the typical limit 
of detection of targeted quantitative PCR (~100 viral copies/
mL), determined based on previous VirCapSeq-VERT experi-
ments using whole blood [11] and feces (unpublished data).
Statistical Analysis
The STROBE reporting guidelines for observational cohort 
studies were followed [18]. Continuous demographic vari-
ables are reported as a mean ± standard deviation (SD) for 
parametric data and median (interquartile range) for skewed 
data, and categorical data as number (%). Participant charac-
teristics, including demographic variables, lifestyle factors, and 
comorbidities, are reported according to T1D status and were 
compared using independent t tests and Fisher’s Exact tests 
for continuous and categorical data, respectively. The socioec-
onomic index for areas (index for relative socioeconomic dis-
advantage) percentile for the postal area in which each patient 
resided was used as an indicator of socioeconomic status (SES) 
[19]. High SES was defined as >75th percentile [20]. Virus posi-
tivity was determined by a positivity threshold of 100 viral reads 
matched by BLAST at the species level.
The differential abundance of viruses between mothers with 
and without T1D was examined using the edgeR package (version 
3.14.0) [21] in R (version 3.3.0). A matrix of read counts, corrected 
for index cross-talk, was generated encompassing all samples and 
detected viruses. Each matrix entry had a count of 1 added to 
avoid issues with division by or log function of zero [22] before 
conversion to counts per million. Data were normalized using the 
Relative Log Expression method with respect to library size [23]. 
Two methods, common and tag-wise [24], were used to estimate 
the biological coefficient of variation. Samples were divided into 
case and control groups, and the “exact” test was used to perform 
hypothesis testing [25]. P values were adjusted to control false-dis-
covery rates with the Benjamini-Hochberg multiple testing cor-
rection procedure [26]. Viruses with an adjusted P  <  .05 were 
identified as displaying statistically significant differential abun-
dance between case and control groups. Heatmaps were created to 
visualize the data using iheatmapr package in R [27].
The richness of vertebrate-infecting viruses in feces was esti-
mated using EstimateS software (version 9.1.0) [28]. Estimates 
used to calculate richness at the genus level and sample-based 
rarefaction curves were computed using prepublished analytical 
formulas [29]. In total, 100 randomizations (runs) were com-
pleted, extrapolating by a factor of 1.0 with estimates (knots) 
at every sample. Estimates of vertebrate-infecting virus rich-
ness in cases were compared with those of controls using a 
non-parametric test, assuming the estimates in cases and controls 
are statistically independent of each other. Rarefaction curves 
were plotted in Microsoft Excel, version 15.3 (Redmond, WA).
The association between maternal T1D and positivity for 
each virus detected in mothers during pregnancy was examined 
using generalized estimating equation (GEE) models. The GEE 
method for the binary outcome of virus positivity at the genus 
level (logit link function) was applied to account for the cor-
relation among longitudinal observations of the same partici-
pant. In the GEE model, virus infection at the genus level was 
the independent variable and the major dependent variable was 
maternal T1D. Other explanatory variables examined were ma-
ternal age at conception, parity, pet ownership, SES, maternal 
body mass index (BMI), education, maternal smoking, and age 
at sample in the model.
Univariate and multivariable analyses were undertaken on 
both study groups. These covariates and factors in the GEE 
model were selected from a larger set of potential covariates by 
forwards and backwards regression. An individual model was 
used for each genus of virus, with independent variables that 
exhibited association with the outcome variable being included 
in multivariable analysis. The GEE models were compared using 
the quasi-likelihood under independence model criterion, and 
the lowest scoring and most parsimonious models are reported. 
An exchange correlation structure was used, and the results 
were expressed as OR determined by the regression coefficient 
expβ, with 95% CIs. Frequency of virus positivity limited multi-
variable analysis to the 5 most frequent genera of virus detected 
in both study groups. Statistical analyses were performed using 
IBM SPSS Statistics, version 24.0 (Chicago, IL). Statistical sig-
nificance was defined as P ≤ .05.
RESULTS
The pregnancy gut virome of women with and without T1D 
was characterized using VirCapSeq-VERT on 124 fecal spec-
imens collected from 61 mothers (n  =  35 with T1D, n  =  26 
without T1D) in the ENDIA study (Supplementary Table 1). 
The mean (±SD) age of mothers at conception was 32 ± 4 years 
and BMI was 27  ±  6  kg/m2. Compared to women without 
T1D, women with T1D gave birth at a significantly younger 
age, after a shorter gestational length, and had fewer children 
(Supplementary Table 1).
High-throughput sequencing generated ~2 billion raw reads, 
which reduced to 1.6 billion reads after filtration of host and 
primer sequences. This equated to 12.7  ±  4.2 million filtered 
reads per sample. In total, 29 genera of eukaryotic viruses 
were detected, and 63% of samples (78 of 124) tested positive 
for at least 1 virus (Figure 1). Members of the Picobirnavirus, 
Parechovirus, and Enterovirus (EV) genera were among 
the most frequent vertebrate-infecting viruses sequenced. 
Although nonvertebrate-infecting viruses were excluded from 
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VirCapSeq-VERT enrichment, tobamoviruses were frequently 
detected, suggesting that plant viruses are highly abundant in 
the gut during pregnancy and prevalent in human feces [30]. 
Although not reaching statistical significance, there was a trend 
to higher virus positivity in mothers with T1D versus without 
(64% vs 50%; P = .14). Rarefaction analysis revealed no differ-
ence in the richness of vertebrate-infecting viruses between 
women with and without T1D (Supplementary Figure 1), sug-
gesting that all participants were exposed to a comparable com-
munity of viruses, independent of their T1D status.
Examination of longitudinal samples from 49 of 61 participants 
(n = 28 with T1D, n = 21 without T1D) identified alphapapillo-
maviruses, circoviruses, parechoviruses, and picobirnaviruses 
in multiple trimesters of pregnancy within individuals (Figure 
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Figure 1. Viruses detected using VirCapSeq-VERT. Heatmap of viral reads (log2 scale) sequenced in 124 fecal samples collected from 35 women with type 1 diabetes (T1D) 
(n = 69 samples) and 26 without (n = 55 samples) during pregnancy. Only viruses with ≥100 reads matched by Basic Local Alignment Search Tool (BLAST) at the species level 
were included and represented at the genus level. Number of viruses detected per specimen, frequency of each virus within the case or control group, and the mean log read 
counts are summarized by bar charts.
D
ow
nloaded from
 https://academ
ic.oup.com
/ofid/article-abstract/6/2/ofz025/5290392 by U
niversity of Adelaide user on 22 M
ay 2019
Pregnancy Gut Virome and Type 1 Diabetes • ofid • 5
2). This may indicate persistent or recurring infection by closely 
related strains. There was no difference in the proportion of 
virus-positive samples across the 3 trimesters (P = .95). Chicken 
anaemia virus, genus Gyrovirus, and plant virus, pepper mild 
mottle virus, genus Tobamovirus were also detected across mul-
tiple trimesters, but these most likely originated from dietary 
intake [30].Two viruses were more prevalent in women with 
T1D: picobirnaviruses (33% vs 9%; OR = 4.2; 95% CI, 1.0–17.1; 
P  =  .046) and tobamoviruses (22% vs 9%; OR  =  3.2; 95% CI, 
1.1–9.3; P = .037). In multivariable GEE models, the higher odds 
of having picobirnaviruses and tobamoviruses in women with 
T1D remained significant after adjustment for maternal age. In 
addition, there was a trend towards higher rates of gyroviruses, 
chloroviruses, and carlaviruses in women with T1D, but dif-
ferences did not reach statistical significance. The frequency of 
EV did not differ between the 2 maternal groups; however, sig-
nificant differences in EV types were observed. Coxsackievirus 
A2 (CVA2), CVB4, CVB5, Rhinovirus B, and ECHOviruses 
were detected exclusively in women with T1D, whereas CVA6, 
CVA10, CVA14, and EV71 were present only in mothers without 
T1D (Supplementary Table 2).
Differential abundance analysis identified 77 virus types 
with ≥2-fold significant difference (P < .02) between pregnant 
women with T1D versus those without, with a false discovery 
rate <5% (Figure 3 and Supplementary Data). Among the top 
15 differentially abundant viruses were 3 EV-B types (CVB4, 
CVB3, and ECHOvirus E18), all present at higher abundance in 
women with T1D (Table 1). In contrast, 4 EV-A types (CVA10, 
CVA16, CVA5, and CVA14) were more abundant during preg-
nancy in women without T1D.
DISCUSSION
We demonstrated that eukaryotic viruses are prevalent in the 
gut of women during pregnancy, and that women with T1D 
are more likely to harbor picobirnaviruses and tobamoviruses 
compared with women without T1D. Furthermore, we found 
significant differences in viral abundance between women with 
and without T1D, including 8 EV B types that were all present 
at a higher abundance in women with T1D. These results dem-
onstrate a distinct profile of viruses in women with T1D in 
pregnancy.
The pathogenicity of picobirnaviruses in humans remains 
to be definitively established. A weak association with gastro-
enteritis in animals has been found, whereas in humans they 
are only considered as possible opportunistic pathogens [31]. 
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Figure 2. Longitudinal changes in the gut virome during pregnancy. Presence-absence heatmap of viruses detected over multiple trimesters of pregnancy (T1, T2, and T3) 
in women with type 1 diabetes (n = 28 individuals) and without (n = 21 individuals).
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Figure 3. Viruses differentially abundant between the gut of women with and 
without type 1 diabetes during pregnancy. Volcano plot of viruses with ≥2-fold dif-
ference (marked by vertical dotted lines) in abundance between pregnant women 
with and without type 1 diabetes. Only differences with false discovery rate below 
5% (P  <  .05) as determined by edgeR are represented. Species A  (EV-A) and B 
enteroviruses (EV-B) are marked in red and blue, respectively. All other viruses rep-
resented in gray.
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Most recently, picobirnaviruses were detected at high levels in 
patients with human immunodeficiency virus [32] and graft-
versus-host disease [33], leading to the proposal that they may 
serve as a biomarker of immunosuppression. Thus, it is plau-
sible that a higher prevalence of picobirnaviruses in women 
with T1D could be reflective of impaired antiviral defence. 
Tobamoviruses are not known to be pathogenic to humans and 
are commonly thought to be introduced to the gut through diet 
[30, 34]. Therefore, their higher prevalence in women with T1D 
during pregnancy may reflect differences in diet or consump-
tion of contaminated drinking water [35]. Alternatively, there 
may be other factors involved such as gut permeability and in-
testinal inflammation, which are both increased in individuals 
with T1D [36] and may prevent effective clearance of dietary 
viruses. Our frequent detection of tobamoviruses in feces is 
consistent with other virome studies, including a recent study 
of 5 mother-infant pairs [30, 37].
The predominance of EV-B types found in pregnant women 
with T1D is consistent with higher rates of EV-B observed 
in individuals with T1D versus healthy controls [38–40]. 
Furthermore, the greater abundance of CVB4 in women with 
T1D complements the body of molecular and epidemiological 
evidence implicating CVB4 in T1D pathogenesis [39, 41–44]. 
In contrast, EV-A types were more prevalent and present at a 
higher abundance in pregnant women without T1D (Figure 
3). This contrasts results obtained from children in the Finnish 
Diabetes Prediction and Prevention (DIPP) study that found 
a higher rate of EV-A infections in cases who developed T1D 
compared with matched controls, during a time window more 
than 12 months before the first detection of islet autoantibody 
[45]. The result also contrasts our own findings in the Australian 
Viruses In the Genetically at Risk (VIGR) study [46], where we 
also found a predominance of EV-A viruses in feces of children 
before or at the time of the first islet autoantibody detection 
when compared with matched controls (Kim et al [47]).
A recent study examining the intestinal virome changes that 
precede the development of autoimmunity in T1D-susceptible 
children detected circoviruses at a greater abundance and prev-
alence in controls, suggesting that infection with this virus may 
offer protection from the development of T1D [48]. Consistent 
with this hypothesis, circoviruses were exclusively detected in 
women without T1D in our investigation (Figure 1). However, 
our sample size was too small to detect a statistically significant 
difference in frequency, and the case participants examined in 
our study were all women who had a long-standing T1D.
We examined potential confounding factors, in addition to 
T1D, that may influence the risk of virus infection during preg-
nancy. In univariate analysis, younger maternal age was associ-
ated with picobirnaviruses, older maternal age and no tertiary 
education was associated with EVs, and low SES was associated 
with gyroviruses. In multivariable GEE models, all of the afore-
mentioned relationships remained significant except between 
maternal age and picobirnaviruses. Glycemic control may also 
influence susceptibility to infection; however, the majority of 
women with T1D in our study achieved glycemic targets for 
pregnancy.
To the best of our knowledge, this is the first study to examine 
the longitudinal gut virome across all 3 trimesters of pregnancy, 
providing novel baseline data for future gut virome investiga-
tions. Another major strength of this study is the application of 
virome capture sequencing [11, 49], which is the most sensitive 
and comprehensive sequence-based virome characterization tool 
currently available for vertebrate-infecting viruses. This method 
specifically targets all known viruses capable of infecting humans 
Table 1. Top 15 Differentially Abundant Species of Viruses between the Gut of Pregnant Women With Type 1 Diabetes Versus Without
Virus LogFD P Value FDR Rank (Magnitude of FD)
Higher in Women with T1D
Human coxsackievirus B4 11.8 1.70E-27 1.50E-26 1
Human coxsackievirus B3 11.2 1.40E-26 1.10E-25 3
Bathycoccus sp RCC1105 virus BpV2 7.1 2.90E-21 1.50E-20 7
Human adenovirus A 7 3.20E-21 1.60E-20 8
ECHOvirus E18 6 1.60E-19 5.90E-19 15
Lower in Women With T1D
Coxsackievirus A10 −11.5 1.70E-38 1.80E-36 2
Brandmavirus UC1 −9.3 2.90E-35 1.50E-33 4
Phaeocystis globosa virus −7.7 1.30E-31 3.50E-30 5
Porcine picobirnavirus −7.4 3.40E-22 1.90E-21 6
Tomato mosaic virus −7 2.30E-30 4.80E-29 9
Ostreococcus lucimarinus virus OlV4 −6.9 1.70E-29 2.20E-28 10
Coxsackievirus A16 −6.9 1.70E-29 2.20E-28 11
Paramecium bursaria Chlorella virus −6.8 7.70E-30 1.40E-28 12
Coxsackievirus A5 −6.4 4.30E-28 4.80E-27 13
Coxsackievirus A14 −6.4 4.60E-28 4.80E-27 14
Abbreviations: FD, fold difference; FDR, false discovery rate; T1D, type 1 diabetes.
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and other vertebrates, significantly reducing sequences produced 
from host and bacterial background, allowing up to a 10 000-fold 
increase in the number of viral reads recovered compared with 
conventional virome sequencing methods. Furthermore, our 
method enabled the examination of both RNA and DNA viruses 
simultaneously [11]. Despite these strengths, the interpretation 
of our virome data is limited by the fact that sequencing cannot 
differentiate between the presence of viral genomes in the gut 
versus actively replicating viruses. In addition, the absence of a 
nonpregnant control group precluded the analysis of the effect of 
pregnancy on virus infection in this study.
Given the results of our recent systematic review and 
meta-analysis of 2992 women and children that demonstrated 
a significant association between maternal virus infection in 
pregnancy and T1D in the offspring [8], future studies could 
be aimed at examining the impact of maternal virus infections 
on the development of islet autoimmunity and T1D in the off-
spring. For this purpose, the offspring of women examined in 
this study are being followed longitudinal for these 2 outcomes 
as part of the ENDIA study, a prospective cohort study following 
at risk children. The characterization of the gut virome in these 
mother-infant pairs will allow identification of potential ver-
tical transmission of viruses (currently underway). The impact 
of diet on the gut virome will also be examined. The virome of 
other potential sources of vertical transmission should also be 
investigated such as the oral, skin, breastmilk, and the vaginal 
virome, which has been recently shown to be of clinical impor-
tance for its potential contribution to preterm birth [50].
CONCLUSIONS
In conclusion, our findings provide novel insight into the di-
versity and dynamics of the gut virome during pregnancy and 
identify T1D and maternal age as key factors influencing virus 
infection in pregnancy. We show a novel potential association 
between T1D and picobirnaviruses and demonstrate a distinct 
profile of viruses during pregnancy in women with T1D, pro-
viding novel targets for prevention studies.
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